Cenobamate
10 NDCs across 1 manufacturer|0 Generic,10 Brand
Cenobamate is used to treat partial epilepsies, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 10, 2020. In 2024, Medicare Part D spent $165 million on Cenobamate across 117,000 claims for 13,000 beneficiaries.
Cenobamate is available as 10 NDCs from 1 manufacturer (0 generic, 10 brand), with NADAC prices from $3.91 to $42.91 per EA — the most expensive product costs about 11× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
0G / 10B
Manufacturers
1
competing in market
Price Spread
$3.91 – $42.91
per EA
7d Activity
avg -0.0% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
SK Life Science, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing CENOBAMATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XCOPRI 150-200 MG TITRATION PK | $42.9098 per EA | -0.18% |
XCOPRI 50-100 MG TITRATION PAK | $42.7146 per EA | -0.12% |
XCOPRI 350 MG DAILY DOSE PACK | $42.6994 per EA | — |
XCOPRI 25 MG TABLET | $39.8819 per EA | -0.01% |
XCOPRI 200 MG TABLET | $39.8775 per EA | +0.02% |
XCOPRI 100 MG TABLET | $39.8715 per EA | -0.02% |
XCOPRI 150 MG TABLET | $39.8629 per EA | -0.01% |
XCOPRI 50 MG TABLET | $39.8567 per EA | +0.02% |
XCOPRI 250 MG DAILY DOSE PACK | $21.3688 per EA | -0.02% |
XCOPRI 12.5-25 MG TITRATION PK | $3.9104 per EA | 0.00% |
Frequently Asked Questions
What is Cenobamate used to treat?
Cenobamate is used to treat partial epilepsies, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Cenobamate?
In 2024, Medicare Part D spent $165 million on Cenobamate across 117,000 claims for 13,000 beneficiaries.
How many Cenobamate products are on the market?
The Cenobamate drug market contains 10 NDCs from 1 manufacturer — 0 generic and 10 brand products.
What is the price range for Cenobamate?
NADAC reference prices for Cenobamate range from $3.9104 to $42.9098 per EA — the most expensive product costs about 11× the cheapest.
Which manufacturers make Cenobamate?
1 manufacturer lists Cenobamate in NADAC. Ranked by number of NDCs, the largest are SK Life Science, Inc. (10).
How has the price of Cenobamate changed recently?
Over the past 7 days, 2 Cenobamate NDCs rose and 6 fell, with a market-wide average change of -0.0%.